Exploring the Neuroprotective and Neuropsychiatric Symptom Management Potential of Ketamine in Alzheimer's Disease.
Cureus June 1, 2025 Amy Avakian, Zachary I Merhavy 1 citation
Ketamine, an anesthetic that blocks NMDA receptors, may offer new ways to manage Alzheimer's disease by improving communication between brain cells and reducing inflammation. The review describes how ketamine could help with depression and agitation that often accompany Alzheimer's, though these results are still preliminary and more research is needed to confirm its safety and effectiveness.